Your browser is no longer supported. Please, upgrade your browser.
Settings
CTLT Catalent, Inc. daily Stock Chart
CTLT [NYSE]
Catalent, Inc.
Index- P/E46.18 EPS (ttm)0.86 Insider Own0.70% Shs Outstand127.55M Perf Week-2.18%
Market Cap5.09B Forward P/E22.74 EPS next Y1.76 Insider Trans-10.26% Shs Float124.56M Perf Month16.70%
Income109.80M PEG5.15 EPS next Q0.19 Inst Own- Short Float2.50% Perf Quarter6.51%
Sales2.08B P/S2.45 EPS this Y-2.20% Inst Trans-1.72% Short Ratio2.79 Perf Half Y40.25%
Book/sh5.78 P/B6.90 EPS next Y9.21% ROA3.40% Target Price38.57 Perf Year55.92%
Cash/sh2.41 P/C16.58 EPS next 5Y8.98% ROE17.10% 52W Range21.83 - 42.22 Perf YTD48.00%
Dividend- P/FCF31.87 EPS past 5Y31.00% ROI7.30% 52W High-8.29% Beta-
Dividend %- Quick Ratio1.80 Sales past 5Y4.10% Gross Margin31.50% 52W Low77.37% ATR1.01
Employees10800 Current Ratio2.30 Sales Q/Q15.90% Oper. Margin11.10% RSI (14)50.37 Volatility1.85% 2.55%
OptionableYes Debt/Eq2.87 EPS Q/Q-1.60% Profit Margin5.30% Rel Volume0.78 Prev Close39.90
ShortableYes LT Debt/Eq2.84 EarningsAug 28 AMC Payout0.00% Avg Volume1.11M Price38.72
Recom2.10 SMA20-0.62% SMA505.62% SMA20022.58% Volume693,432 Change-2.96%
Sep-13-17Initiated Needham Hold
Sep-08-17Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
Dec-01-16Initiated Goldman Neutral
Oct-20-16Initiated KeyBanc Capital Mkts Overweight $29
Jun-21-16Upgrade Wells Fargo Market Perform → Outperform
Jun-20-16Upgrade BofA/Merrill Neutral → Buy
May-05-16Downgrade BofA/Merrill Buy → Neutral
Apr-21-16Downgrade Morgan Stanley Overweight → Equal-Weight
Feb-10-16Reiterated Deutsche Bank Hold $31 → $24
Dec-22-15Downgrade Wells Fargo Outperform → Market Perform
Dec-09-15Downgrade Raymond James Outperform → Mkt Perform
Nov-04-15Reiterated Deutsche Bank Hold $33 → $31
Sep-10-15Downgrade Jefferies Buy → Hold $32 → $29
Feb-12-15Reiterated Deutsche Bank Hold $26 → $33
Sep-09-14Initiated William Blair Outperform
Sep-19-17 12:51PM  Catalent Dips On $950 Million Acquisition Of Cook Pharmica Investor's Business Daily
11:37AM  Catalent bolsters biopharma business with Cook Pharmica buy Reuters
11:09AM  M&A News: Catalent Inc (CTLT) to Buy Cook Pharmica in $950M Deal InvestorPlace
07:30AM  Catalent to Acquire Cook Pharmica for $950 Million Business Wire
Sep-18-17 07:40AM  Earnings Review and Free Research Report: Catalents Revenue Grew 16%; Adjusted EPS Jumped 25% ACCESSWIRE
Sep-15-17 08:03AM  See what the IHS Markit Score report has to say about Catalent Inc. Markit
Sep-13-17 07:00AM  Earnings Review and Free Research Report: Lannetts Sales and Earnings Results Met Expectations ACCESSWIRE
Sep-04-17 08:04AM  See what the IHS Markit Score report has to say about Catalent Inc. Markit
Sep-01-17 07:24PM  ETFs with exposure to Catalent, Inc. : September 1, 2017 Capital Cube
Aug-31-17 08:11AM  Edited Transcript of CTLT earnings conference call or presentation 28-Aug-17 8:45pm GMT Thomson Reuters StreetEvents
Aug-30-17 03:51PM  Catalent, Inc.: Strong price momentum but will it sustain? Capital Cube
01:28PM  Catalent, Inc. :CTLT-US: Earnings Analysis: 2017 By the Numbers : August 30, 2017 Capital Cube
08:36AM  Strength Seen in Catalent (CTLT): Stock Soars 13.9% Zacks
03:00AM  Stocks With Rising Relative Price Strength: Catalent Investor's Business Daily
Aug-29-17 04:21PM  Why Movado Group, Catalent, and ImmunoGen Jumped Today Motley Fool +13.89%
11:42AM  Why Catalent Inc. Rose as Much as 17% This Morning Motley Fool
08:13AM  3 Stocks to Watch on Tuesday: Nike Inc (NKE), Finish Line Inc (FINL) and Catalent Inc (CTLT) InvestorPlace
07:58AM  Early movers: BBY, MRK, FINL, AZN, PX, BHP, CTLT, HDS, MOV, JILL & more CNBC
Aug-28-17 09:37PM  Catalent tops Street 4Q forecasts Associated Press
05:41PM  After-hours buzz: FINL, UA, NKE & more CNBC
04:15PM  Catalent, Inc. Reports Fourth Quarter and Full Year 2017 Results Business Wire
Aug-25-17 08:02AM  See what the IHS Markit Score report has to say about Catalent Inc. Markit
Aug-24-17 08:03AM  See what the IHS Markit Score report has to say about Catalent Inc. Markit
Aug-23-17 04:15PM  Catalent, Inc. to Present at the Morgan Stanley 15th Annual Global Healthcare Conference Business Wire
08:59AM  Catalent, Inc. breached its 50 day moving average in a Bullish Manner : CTLT-US : August 23, 2017 Capital Cube
Aug-17-17 08:03AM  See what the IHS Markit Score report has to say about Catalent Inc. Markit
Aug-12-17 08:02AM  See what the IHS Markit Score report has to say about Catalent Inc. Markit
Aug-11-17 08:02AM  IHS Markit Score Update: Rise in demand for ETFs holding Catalent Inc is a positive for its shares Markit
Aug-10-17 08:05AM  IHS Markit Score Update: Drop in demand for ETFs holding Catalent Inc is a negative sign for its shares Markit
08:00AM  No More Pricks Quick Dissolvable Tablet is Set to Disrupt the Vaccine Industry Business Wire
Jul-31-17 05:51PM  Catalent, Inc. Value Analysis (NYSE:CTLT) : July 31, 2017 Capital Cube
Jul-25-17 08:19AM  Catalent, Inc. breached its 50 day moving average in a Bullish Manner : CTLT-US : July 25, 2017 Capital Cube
Jul-19-17 04:15PM  Catalent, Inc. Announces Fourth Quarter and Fiscal Year 2017 Earnings Conference Webcast Business Wire
Jul-14-17 09:09AM  Catalent, Inc. breached its 50 day moving average in a Bearish Manner : CTLT-US : July 14, 2017 Capital Cube
Jul-03-17 03:03PM  ETFs with exposure to Catalent, Inc. : July 3, 2017 Capital Cube
Jun-19-17 03:09PM  ETFs with exposure to Catalent, Inc. : June 19, 2017 Capital Cube
Jun-16-17 02:28PM  Catalent, Inc. :CTLT-US: Earnings Analysis: Q3, 2017 By the Numbers : June 16, 2017 Capital Cube
Jun-06-17 04:15PM  Catalent, Inc. to Present at William Blair & Companys 37th Annual Growth Stock Conference Business Wire
May-25-17 04:15PM  Catalent, Inc. to Present at the Jefferies 2017 Healthcare Conference Business Wire
May-12-17 11:21AM  Medical Stock Bolts Higher On 81% Spike In Earnings Investor's Business Daily
May-09-17 08:36PM  Edited Transcript of CTLT earnings conference call or presentation 4-May-17 8:45pm GMT Thomson Reuters StreetEvents
May-08-17 03:48AM  Catalent (CTLT) Shows Strength: Stock Adds 9.8% in Session Zacks
May-05-17 02:57PM  Here's Why Catalent Inc. Rose as Much as 20.3% Today Motley Fool +9.75%
May-04-17 07:39PM  Catalent beats Street 3Q forecasts Associated Press
04:15PM  Catalent, Inc. Reports Third Quarter Fiscal Year 2017 Results Business Wire
Apr-27-17 04:43PM  Catalent, Inc. Value Analysis (NYSE:CTLT) : April 27, 2017 Capital Cube
Apr-26-17 04:15PM  Catalent, Inc. to Present at the Bank of America Merrill Lynch 2017 Healthcare Conference Business Wire
08:41AM  Catalent, Inc. breached its 50 day moving average in a Bullish Manner : CTLT-US : April 26, 2017 Capital Cube
Apr-17-17 04:15PM  Catalent, Inc. Announces Third Quarter Fiscal Year 2017 Earnings Conference Webcast Business Wire
Apr-06-17 08:15AM  Blog Coverage Gurnet Point Acquired Innocoll for Approximately $209 Million in Aggregate Accesswire
Mar-23-17 08:05AM  Catalent, Inc. breached its 50 day moving average in a Bullish Manner : CTLT-US : March 23, 2017 Capital Cube
Feb-22-17 04:15PM  Catalent, Inc. to Present at the Raymond James 38th Annual Institutional Investors Conference Business Wire
Feb-17-17 09:30AM  Cluster of Insider Sales at IT Research Firm Should You Sell? Guys at Baron Say No; Plus Other Insider Trading Insider Monkey
Feb-16-17 07:30AM  Catalent Completes Accucaps Acquisition to Expand Softgel Development and Manufacturing Capabilities and Capacity Business Wire
Feb-14-17 03:35PM  ETFs with exposure to Catalent, Inc. : February 14, 2017 Capital Cube
Feb-10-17 01:04PM  CATALENT, INC. Financials
Feb-09-17 04:33PM  CATALENT, INC. Files SEC form 8-K/A, Change in Directors or Principal Officers
10:46AM  Catalent, Inc. :CTLT-US: Earnings Analysis: Q2, 2017 By the Numbers : February 9, 2017 Capital Cube
Feb-07-17 03:04AM  Edited Transcript of CTLT earnings conference call or presentation 6-Feb-17 9:45pm GMT Thomson Reuters StreetEvents
Feb-06-17 04:32PM  Catalent beats Street 2Q forecasts Associated Press
04:18PM  CATALENT, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:15PM  Catalent, Inc. Reports Second Quarter Fiscal Year 2017 Results Business Wire
07:07AM  Q2 2017 Catalent Inc Earnings Release - After Market Close
Jan-18-17 04:15PM  Catalent, Inc. Announces Second Quarter Fiscal Year 2017 Earnings Conference Webcast Business Wire
Jan-12-17 07:35AM  Trump criticism leads to falling stock prices at these Tampa employers at bizjournals.com
Jan-10-17 06:05AM  CATALENT, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Dec-15-16 04:15PM  Catalent, Inc. to Present at the 35th Annual J.P. Morgan Health Care Conference Business Wire
Dec-12-16 07:36AM  CATALENT, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligat
07:30AM  Catalent Completes Repricing of Credit Agreement Business Wire
Dec-02-16 08:47AM  Here is What Hedge Funds Think About Catalent Inc (CTLT) at Insider Monkey
08:06AM  CATALENT, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:58AM  Catalent Announces Pricing of Private Offering of Euro-Denominated Senior Unsecured Notes Due 2024 Business Wire
Dec-01-16 07:13AM  Coverage initiated on Catalent by Goldman
Nov-30-16 12:13PM  ETFs with exposure to Catalent, Inc. : November 30, 2016
Nov-29-16 07:28AM  Catalent, Inc. breached its 50 day moving average in a Bearish Manner : CTLT-US : November 29, 2016
Nov-28-16 01:14PM  Catalent Pharma Solutions, Inc. -- Moody's upgrades Catalent's senior secured debt to Ba3; assigns B3 to unsecured notes at Moody's
08:08AM  CATALENT, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
08:00AM  Catalent Announces Launch of Private Offering of $400 Million (U.S. Dollar Equivalent) of Euro-Denominated Senior Unsecured Notes Due 2024 Business Wire
07:30AM  Catalent Acquires Accucaps to Expand Softgel Development and Manufacturing Capabilities and Capacity Business Wire
Nov-11-16 07:13AM  Catalent, Inc. breached its 50 day moving average in a Bullish Manner : CTLT-US : November 11, 2016
Nov-10-16 12:12PM  ETFs with exposure to Catalent, Inc. : November 10, 2016
Nov-08-16 09:52AM  Catalent, Inc. :CTLT-US: Earnings Analysis: Q1, 2017 By the Numbers : November 8, 2016
01:30AM  Edited Transcript of CTLT earnings conference call or presentation 7-Nov-16 9:45pm GMT
Nov-07-16 06:08PM  Catalent beats Street 1Q forecasts
04:48PM  CATALENT, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:15PM  Catalent, Inc. Reports First Quarter Fiscal Year 2017 Results Business Wire
07:07AM  Q1 2017 Catalent Inc Earnings Release - After Market Close
Nov-04-16 08:54AM  Drug Stocks Earnings Roster for Nov 7: HZNP, ACAD & More
Oct-31-16 04:25PM  CATALENT, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
04:15PM  Catalent, Inc. Appoints Uwe Röhrhoff to its Board of Directors Business Wire
Oct-12-16 04:45PM  Catalent, Inc. Announces First Quarter Fiscal Year 2017 Earnings Conference Webcast Business Wire
08:47AM  Catalent, Inc. breached its 50 day moving average in a Bearish Manner : CTLT-US : October 12, 2016
Sep-26-16 12:55PM  Bullish and Bearish Reversals for the Week
09:03AM  New Strong Sell Stocks for September 26th
Sep-13-16 07:30AM  Catalent to Acquire Pharmatek, Adding Expanded Drug Development Services and Spray Drying Technology Business Wire
Sep-12-16 05:29PM  CATALENT, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Sep-09-16 04:58PM  CATALENT, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Sep-08-16 09:07AM  2 Big Companies and 1 Small One to Target in the Pharma/Biotech Space
08:30AM  Catalent, Inc. breached its 50 day moving average in a Bearish Manner : CTLT-US : September 8, 2016
Sep-07-16 12:10PM  Catalent (CTLT) Stock Slumps on Secondary Stock Offering -6.17%
Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide. It operates through three segments: Softgel Technologies, Drug Delivery Solutions, and Clinical Supply Services. The Softgel Technologies segment offers formulation, development, and manufacturing services for softgels, which are used in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, and unit-dose cosmetics. Its principal softgel technologies include traditional softgel capsules, as well as Vegicaps and OptiShell capsules. The Drug Delivery Solutions segment formulates, develops, and manufactures prescription, and consumer and animal health products using OptiMelt, OptiPact, OptiForm, and Zydis, as well as other proprietary and conventional drug delivery technologies, such as prefilled syringes; manufactures blow-fill seal unit dose consisting of ADVASEPT technology; develops biologic cell line, such as GPEx and SMARTag technologies; provides biologics; and offers analytical and bioanalytical development, and testing services. This segment also provides analytical chemical, and cell-based testing and scientific; stability testing; respiratory products formulation and manufacturing; micronization and particle engineering; regulatory consulting; and bioanalytical testing services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics clinical trials; FastChain demand-led clinical supply services; clinical e-solutions and informatics; and comparator sourcing services. The company serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. Catalent, Inc. was founded in 2007 and is headquartered in Somerset, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dolan ChristineSVP - Product DevelopmentAug 29Option Exercise18.579,150169,91627,007Aug 31 10:41 AM
Miyamoto LanceSVP - Human ResourcesAug 29Option Exercise12.1439,138475,13560,935Aug 31 03:43 PM
Dolan ChristineSVP - Product DevelopmentAug 29Sale38.751,59461,76819,449Aug 31 10:41 AM
Miyamoto LanceSVP - Human ResourcesAug 29Sale38.228,512325,32941,081Aug 31 03:43 PM
Dolan ChristineSVP - Product DevelopmentAug 01Sale34.8574525,96314,058Aug 03 05:31 PM
WALSH MATTHEW MSee RemarksJun 08Option Exercise11.8474,651884,064168,363Jun 12 04:36 PM
Johnson SharonSee RemarksApr 25Option Exercise14.8270,7161,047,66853,670Apr 27 11:02 AM
Johnson SharonSee RemarksApr 25Sale29.009,160265,64022,520Apr 27 11:02 AM
Downie WilliamSee RemarksMar 20Option Exercise13.2758,103770,99464,147Mar 22 07:06 PM
Downie WilliamSee RemarksMar 20Sale28.608,262236,29328,976Mar 22 07:06 PM
Chiminski John RSee RemarksMar 20Sale28.762015,781186,507Mar 20 05:31 PM
Chiminski John RSee RemarksMar 16Option Exercise10.71206,6842,213,586393,191Mar 20 05:31 PM
Chiminski John RSee RemarksMar 16Sale28.6273,6182,106,756186,708Mar 20 05:31 PM
MOREL DONALD E JRDirectorFeb 15Buy29.2710,000292,70018,799Feb 16 04:42 PM